EWM
Essex Woodlands Management Portfolio holdings
AUM $279M
1-Year Return
29.39%
This Quarter Return
-5.81%
1 Year Return
+29.39%
3 Year Return
+195.65%
5 Year Return
+90.32%
10 Year Return
+273.6%
AUM
$438M
AUM Growth
-$42.1M
(-8.8%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 96.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
1
DELISTED
Abiomed Inc
ABMD
| $163M | 37.26% |
1,450,000
| – | – |
|
|
RVNC
2
DELISTED
Revance Therapeutics, Inc.
RVNC
| $95.1M | 21.68% |
4,592,047
| – | – |
|
|
ENTL
3
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $72.3M | 16.5% |
3,813,197
| – | – |
|
4
Axogen
AXGN
$753M
| $43.8M | 9.98% |
4,861,111
| – | – |
|
|
CORI
5
DELISTED
Corium International, Inc.
CORI
| $38M | 8.66% |
9,353,304
| – | – |
|
|
ELGX
6
DELISTED
Endologix Inc
ELGX
| $14.2M | 3.24% |
125,747
| – | – |
|
7
MediciNova
MNOV
$60.8M
| $7.06M | 1.61% |
1,170,370
| – | – |
|
8
Ligand Pharmaceuticals
LGND
$3.23B
| $2.42M | 0.55% |
52,727
| – | – |
|
|
ACUR
9
DELISTED
Acura Pharmaceuticals Inc
ACUR
| $1.51M | 0.34% |
1,956,397
| – | – |
|
10
Gyre Therapeutics
GYRE
$718M
| $778K | 0.18% |
10,483
| – | – |
|